Feline coronavirus (FCoV) is a frequent viral infection in cats. It generally exists in a subclinical “enteric” state, but it can also mutate into a pathological state causing feline infectious peritonitis (FIP), a potentially fatal disease if left untreated. Despite FCoV’s prevalence, its early and accurate detection remains a challenge for many veterinarians.
The Astéria Feline Coronavirus kit was developed to address that issue by offering a reliable and effective tool to detect FCoV in the presence of suggestive signs or symptoms. The kit enables the detection of the enteric or muted, PIF-causing version of FCoV in either blood or effusion fluid.
Easy to use and rapid results
The Astéria Feline Coronavirus test uses reverse-transcription loop-mediated isothermal amplification (RT-LAMP) technology to accurately diagnose infection with FCoV in only 40 minutes. The interest of the test is to fluidify the clinical course, enabling a more rapid deployment of pertinent treatments, and isolation if necessary, for the cat. All parties benefit from the test: the pet owner’s expectations are better addressed, the cat’s treatments are optimized, and the teams develop new competencies and pragmatic approaches.
Keeping with Enalees’s “real-world use” approach, Astéria Feline Coronavirus is an easy- and ready-to-use kit covering all steps from sample preparation through to amplification. Veterinarians can thus establish a diagnosis at their own clinic or even during house calls; there is no need to send samples to an exterior lab.
The launch of Astéria Feline Coronavirus is a new milestone in Enalees’s commitment to improving veterinary care.
Alban Lacaze, Sales & Marketing Director: “We are proud to present Astéria® Feline Coronavirus, a product reflecting our engagement for innovation and quality. The new test gives veterinarians a complementary tool to improve the rapid diagnosis and management of viral infections in cats. We strongly believe that this kit will greatly improve clinical practice. “
